new
   Channels for Purchasing Tibsovo® (Ivosidenib)
502
Jan 07, 2026

Tibsovo® (Ivosidenib) is an oral targeted therapy indicated for IDH1 mutations. It has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of specific types of acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and cholangiocarcinoma.

Channels for Purchasing Tibsovo® (Ivosidenib)

Overseas Purchase

Patients may consult and purchase the medication at hospital pharmacies or licensed drugstores in countries/regions where Tibsovo® has been officially launched.

Given that drug prices may be affected by regional differences, exchange rate fluctuations and other factors, patients are advised to make a detailed budget and plan in advance before purchasing.

Purchase via Medical Service Providers

Patients may consult domestic overseas medical service agencies that have partnerships with international pharmacies or pharmaceutical manufacturers.

These agencies typically offer legitimate import channels, along with professional consultation and guidance services.

Precautions for Purchasing Tibsovo® (Ivosidenib)

Genetic Testing

Complete genetic testing: Confirm the IDH1 mutation status through a qualified testing institution.

Obtain a professional prescription: A prescription must be issued by a hematologist or oncologist based on the test results and clinical assessment of the patient’s condition. Purchasing prescription drugs without a valid prescription is illegal and dangerous.

Verify Drug Information and Source

Outer packaging inspection: Confirm the accuracy of details including the brand name (TIBSOVO), active ingredient (Ivosidenib), dosage strength (e.g., 250 mg), and manufacturer (Servier Pharmaceuticals LLC).

Batch number and expiration date check: Ensure these details are clearly printed and verifiable through relevant official systems.

How to Distinguish Authentic Tibsovo® (Ivosidenib) from Counterfeits

Inspect Packaging and Tablet Appearance

Packaging quality: Authentic products feature high-quality printing, clear coloration, and standard packaging materials. Be wary of products with shoddy packaging, typographical errors, or ambiguous information.

Tablet appearance: The 250 mg strength of Ivosidenib is a blue, oval, film-coated tablet, engraved with “IVO” on one side and “250” on the other.

Carefully compare the tablet’s color, shape, and engravings against the official descriptions.

Check Traceability Information

Batch number verification: Legitimate drugs are labeled with a unique batch number and expiration date on the outer packaging.

Verification can be conducted through official channels of the partner pharmacies of the service provider or the pharmaceutical manufacturer (assistance from the service provider may be required).

Regulatory code verification: Drugs in some countries/regions are affixed with an official regulatory code, which can be verified by scanning the code via designated official websites or mobile applications.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Ivosidenib(Tibsovo)
Adult patients with relapsed or refractory acute myeloid leukemia.
RELATED ARTICLES
What Are the Indications of Ivosidenib (Tibsovo)?

Ivosidenib (Tibsovo) is an important isocitrate dehydrogenase-1 (IDH1) inhibitor, providing an innovative treatment...

Wednesday, January 7th, 2026, 11:50
Dosage, Administration and Recommended Dose of Ivosidenib (Tibsovo)

Ivosidenib (Tibsovo) is the first targeted therapy indicated for acute myeloid leukemia (AML) with IDH1 mutations,...

Wednesday, January 7th, 2026, 11:32
Channels for Purchasing Tibsovo® (Ivosidenib)

Tibsovo® (Ivosidenib) is an oral targeted therapy indicated for IDH1 mutations. It has been approved by the U.S....

Wednesday, January 7th, 2026, 11:24
Adverse Reactions of Ivosidenib (Tibsovo)

Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of...

Thursday, December 18th, 2025, 11:48
RELATED MEDICATIONS
Enasidenib
Treatment of relapsed or refractory acute myeloid leukemia (AML) in adult...
TOP
1
Glasdegib
DAURISMO is indicated in combination with low-dose cytarabine for the treatment...
TOP
2
Xospata
Treatment of relapsed or refractory acute myeloid leukemia (AML) in adults with...
TOP
3
Tretinoin
VESANOID is indicated for the induction of remission in adults and pediatric...
Gemtuzumab ozogamicin
Gemtuzumab ozogamicin is a CD33-directed antibody and cytotoxic drug conjugate...
Quizartinib
VANFLYTA is indicated for adult patients with newly diagnosed Acute Myeloid...
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved